Market Cap 122.63M
Revenue (ttm) 0.00
Net Income (ttm) -42.26M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.01
Volume 58,700
Avg Vol 64,044
Day's Range N/A - N/A
Shares Out 25.87M
Stochastic %K 48%
Beta N/A
Analysts Strong Sell
Price Target $24.80

Latest News on CTNM

Contineum Therapeutics to Attend Upcoming Investor Conferences

Nov 13, 2024, 4:05 PM EST - 5 months ago

Contineum Therapeutics to Attend Upcoming Investor Conferences